Humana 2005 Annual Report Download - page 110

(9) Dr. Lord currently serves as Senior Vice President and Chief Innovation Officer having held this position
since September 2002. Prior to that, he served as Senior Vice President and Chief Clinical Strategy and
Innovation Officer from February 2001 to September 2002. Dr. Lord joined the Company in April 2000 as
Senior Vice President and Chief Medical Officer.
(10) Ms. Margulis currently serves as Senior Vice President—Government Relations having held this position
since January 2000. Prior to that, she served as Vice President—Government Affairs from May 1996 to
January 2000. Ms. Margulis joined the Company in November 1985.
(11) Mr. McCulley currently serves as Vice President & Controller (Principal Accounting Officer) having held
this position since August 2004. Prior to that, he served as Vice President & Controller from January 2001
to August 2004, Vice President and Chief Financial Officer of Market Operations from May 2000 to
January 2001. Mr. McCulley joined the company in 1990.
(12) Mr. Moya currently serves as Senior Vice President and Chief Marketing Officer having held this position
since January 2001.
Executive officers are elected annually by the Company’s Board of Directors and serve until their
successors are elected or until resignation or removal. There are no family relationships among any of the
executive officers of the Company.
Corporate Governance Items
We have made available free of charge on or through the Investor Relations section of our Internet web site
(http://www.humana.com) our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Proxy
Statements, and all of our other reports, and, if applicable, amendments to those reports filed or furnished
pursuant to Section 13(a) of the Exchange Act, as soon as reasonably practicable after we electronically file such
material with, or furnish it to, the SEC. Also available on our Internet web site is information about our Board of
Directors, including a determination of independence for each member, the various committees of our Board of
Directors, the charters of these committees, the name(s) of the Directors designated as a financial expert under
rules and regulations promulgated by the SEC, the process for designating a lead director to act at executive
sessions of the non-management Directors, the pre-approval process of non-audit services provided by our
independent accountants, the process by which stockholders can communicate with Directors, the process by
which stockholders can make Director nominations, the Company’s Corporate Governance guidelines, the
Humana Principles of Business Ethics, and the Code of Ethics for the Chief Executive Officer and Senior
Financial Officers. Any waivers or amendments for Directors or Executive Officers to the Principles of Business
Ethics and the Code of Ethics for the Chief Executive Officer and Senior Financial Officers will be promptly
displayed on our web site. The Company will provide any of these documents in print without charge to any
stockholder who makes a written request to: Corporate Secretary, Humana Inc., 500 West Main Street, 27th floor,
Louisville, Kentucky 40202. Additional information about these items can be found in, and is incorporated by
reference to, the Company’s Proxy Statement for the Annual Meeting of Stockholders scheduled to be held on
April 27, 2006.
Audit Committee Financial Expert
The information required by this Item is herein incorporated by reference from our Proxy Statement for the
Annual Meeting of Stockholders scheduled to be held on April 27, 2006 appearing under the caption “Corporate
Governance-Audit Committee” of such Proxy Statement.
Audit Committee Composition and Independence
The information required by this Item is herein incorporated by reference from our Proxy Statement for the
Annual Meeting of Stockholders scheduled to be held on April 27, 2006 appearing under the caption “Corporate
Governance-Committee Composition” of such Proxy Statement.
100